Vitamin D drug formulation: from active substance to therapeutic effects
https://doi.org/10.51793/OS.2022.25.9.001
Abstract
The literature review presents current data on the origin and sources of industrial production of vitamin D, and describes the features of metabolism, biological and pharmacological properties of various vitamin D vitamers. Vitamin D vitamers are groups of structurally similar molecules that differ in the presence of certain functional groups and biological activity. The role of micellization in the mechanisms of absorption and assimilation of cholecalciferol is considered in detail; justified pharmaceutical technologies that improve its bioavailability. Depending on the dosage form and time of appearance in the Russian Federation, it is proposed to classify vitamin D drugs in the Russian Federation into three generations. First generation – fish oil preparations; second-generation drugs – vitamin D in an oil solution; the third generation – vitamin D as part of an aqueous solution of micelles. Preparations of the 3rd last generation, at the moment, are the most modern, as they level out the shortcomings of the previous two generations (fish oil and oil solution), and have the main advantage – high bioavailability, regardless of the patient's gastrointestinal diseases and the composition of the accompanying food (due to the content of finished micelles). The indications for the use of vitamin D preparations for the treatment, prevention and maintenance of the target level of vitamin D in children and adults are summarized, depending on the active substance (cholecalciferol, ergocalciferol) and its dosage form (drops, tablets, capsules).
About the Author
A. S. Dukhanin
Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Aleksandr S. Dukhanin, Dr. of Sci. (Med.), Professor
Federal State Autonomous Educational Institution of Higher Education Pirogov Russian National Research Medical University
Department of Molecular Pharmacology and Radiobiology
117997
1 Ostrovityanova str.
Moscow
References
1. Conlan Roberta, Elizabeth Sherman. «Unraveling the Enigma of Vitamin D». National Academy of Sciences. October 2000. http://www.nasonline.org/publications/beyond-discovery/vitamin-d.pdf.
2. Meza-Meza M. R., Ruiz-Ballesteros A. I., de la Cruz-Mosso U. Functional effects of vitamin D: From nutrient to immunomodulator // Crit Rev Food Sci Nutr. 2022; 62 (11): 3042-3062. DOI: 10.1080/10408398.2020.1862753.
3. Girgis E., Reyad A. A. Vitamin D: Pharmacology and Clinical Challenges in Oral Health Care // J Int Acad Periodontol. 2019; 21 (3): 118-124.
4. Holick M. F. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention // Reviews in endocrine & metabolic disorders. 2017; 18: 153-165.
5. Клинические рекомендации Российской ассоциацией эндокринологов по профилактике и лечению дефицита витамина D у взрослых. – 2021. [Clinical guidelines by the Russian Association of Endocrinologists for the prevention and treatment of vitamin D deficiency in adults, 2021.]
6. Amrein K., Scherkl M., Hoffmann M. et al. Vitamin D deficiency 2.0: an update on the current status worldwide // Eur J Clin Nutr. 2020; 74: 1498-1513. https://doi.org/10.1038/s41430-020-0558-y.
7. Петрушкина А. А. Эпидемиология дефицита витамина D в Российской Федерации / А. А. Петрушкина, Е. А. Пигарова, Л. Я. Рожинская // Остеопороз и остеопатии. – 2018. – 3 (21): 15-20. DOI: https://doi.org/10.14341/osteo10038. [Petrushkina A. A., Pigarova Ye. A., Rozhinskaya L. Ya. Epidemiology of vitamin D deficiency in the Russian Federation // Osteoporoz i osteopatii. 2018; 3 (21): 15-20. DOI: https://doi.org/10.14341/osteo10038 ]
8. Каронова Т. Л. Уровень обеспеченности витамином D у жителей Северо-Западного региона РФ и значение дефицита витамина D для здоровья / Т. Л. Каронова [и др.] // Остеопороз и остеопатии. – 2016. – 2 (19). – 45-46. [Karonova T. L., Mikheyeva Ye. P., Nikitina I. L., Belyayeva O., Todiyeva A. M., Popova P. V., Andreyeva A. T., Globa P. Yu., Beletskaya I. S., Vasil′yeva Ye. Yu., Grineva Ye. N., Galkina O. V. The level of vitamin D sufficiency among residents of the North-West region of the Russian Federation and the significance of vitamin D deficiency for health // Osteoporoz i osteopatii. 2016; 2 (19): 45-46.]
9. Суплотова Л. А. Дефицит витамина D в России: первые результаты регистрового неинтервенционного исследования частоты дефицита и недостаточности витамина D в различных географических регионах страны / Л. А. Суплотова [и др.] // Проблемы эндокринологии. – 2021/ – 2 (66). – 84-92. DOI: https://doi.org/10.14341/probl12736. [Suplotova L. A., Avdeyeva V. A., Pigarova Ye. A., Rozhinskaya L. Ya., Troshina Ye. A. Vitamin D deficiency in Russia: first results of a registry non-interventional study of the incidence of vitamin D deficiency and insufficiency in different geographical regions countries // Problemy endokrinologii. 2021; 2 (66): 84-92. DOI: https://doi.org/10.14341/probl12736 ]
10. Национальная программа «Недостаточность витамина D у детей и подростков Российской Федерации: современные подходы к коррекции» / Союз педиатров России [и др.]. – М.: ПедиатрЪ, 2018. – 96 с. [National program «Vitamin D deficiency in children and adolescents of the Russian Federation: modern approaches to correction». Soyuz pediatrov Rossii [i dr.]. M.: Pediatr, 2018. Р. 96.]
11. Клинические рекомендации Остеопороз, КР87 2021. https://cr.minzdrav.gov.ru/recomend/87_4. [Clinical guidelines Osteoporosis, КР87 2021. https://cr.minzdrav.gov.ru/recomend/87_4.]
12. Государственный реестр лекарственных средств https://grls.rosminzdrav.ru/. [State Register of Medicines https://grls.rosminzdrav.ru/.]
13. Мельниченко Г. А. Профилактика и лечение дефицита витамина D: выбор оптимального подхода / Г. А. Мельниченко [и др.] // Вопросы современной педиатрии. – 2021. – 20 (4). – 338-345. [Mel′nichenko G. A., Namazova-Baranova L. S., Gromova O. A., Drapkina O. M., Karonova T. L., Kulikova K. S., Krupinova Yu. A., Lesnyak O. M., Mazurina N. V., Panov A. A., Pigarova Ye. A., Rozhinskaya L. Ya., Belaya Zh. Ye., Ruyatkina L. A., Suplotova L. A. Prevention and treatment of vitamin D deficiency: choosing the optimal approach // Voprosy sovremennoy pediatrii. 2021; 20 (4): 338-345.]
14. Клинические рекомендации по профилактике и лечению дефицита витамина D у взрослых // Проблемы эндокринологии. – 2016. – 4. – 60-66. [Clinical guidelines for the prevention and treatment of vitamin D deficiency in adults // Problemy endokrinologii. 2016; 4: 60-66.]
15. Hirsch A. L. Industrial Aspects of Vitamin D. Vitamin D. 2011. С. 73-93.
16. Электронная ссылка: https://go.drugbank.com/drugs (дата обращения 14. 04. 2022). [Electronic link: https://go.drugbank.com/drugs (accessed: 14. 04. 2022).]
17. Blomstrand R., Forsgren L. Intestinal absorption and esterification of vitamin D3-1,2-3H in man // Acta Chemica Scandinavica. 1967; 21 (6): 1662-1663. DOI: 10.3891/acta.chem.scand.21-1662.
18. Wadhwa J., Nair A., Kumria R. Self-emulsifying therapeutic system: a potential approach for delivery of lipophilic drugs // Brazilian Journal of Pharmaceutical Sciences. 2011; 47 (3): 447-463.
19. Громова О. А. Витамин D – смена парадигмы / О. А. Громова, И. Ю. Торшин ; Под ред. акад. РАН Е. И. Гусева, проф. И. Н. Захаровой. – М.: Торус Пресс, 2015. – С. 449-453. [Gromova O. A., Torshin I. Y. Vitamin D – paradigm shift / Ed. acad. RAS Guseva E. I., prof. Zakharova I. N. M.: Torus Press, 2015. Рp. 449-453.]
20. Borel P., Caillaud D., Cano N. J. Vitamin D bioavailability: State of the art // Critical Reviews in Food Science and Nutrition. 2015; 55 (9): 1193-205. DOI: 10.1080/10408398.2012.688897.
21. Hollander D., Muralidhara K. S., Zimmerman A. Vitamin D-3 intestinal absorption in vivo: Influence of fatty acids, bile salts, and perfusate pH on absorption // Gut. 1978; 19 (4): 267-272. DOI: 10.1136/gut.19.4.267.
22. Niramitmahapanya S., Harris S. S., Dawson-Hughes B. Type of dietary fat is associated with the 25-hydroxyvitamin D3 increment in response to vitamin D supplementation // The Journal of Clinical Endocrinology and Metabolism. 2011; 96 (10): 3170-3174. DOI: 10.1210/jc.2011-1518.
23. Громова О. А. Комплексное исследование количества и видов насыщенных и полиненасыщенных жирных кислот в составе препаратов / О. А. Громова [и др.] // Медицинский алфавит. – 2019. – 33 (408). – 1-15. [Gromova O. A., Torshin I. Yu., Ruzhitskiy A. O., Zaychik B. Ts. A comprehensive study of the amount and types of saturated and polyunsaturated fatty acids in the composition of preparations // Meditsinskiy alfavit. 2019; 33 (408): 1-15.]
24. Торшин И. Ю. Фармакокинетический анализ препаратов витамина D для перорального приема / И. Ю. Торшин [и др.] // Фармакокинетика и фармакодинамика. – 2018. – (3). – 57-64. [Torshin I. Yu., Gromova O. A., Frolova D. Ye., Grishina T. R., Lapochkina N. P. Pharmacokinetic analysis of vitamin D preparations for oral administration // Farmakokinetika i farmakodinamika. 2018; (3): 57-64.]
25. Инструкция по медицинскому применению лекарственного препарата «Аквадетрим», капли для приема внутрь, 15000 МЕ/мл, РУ П N014088/01. [Instructions for medical use of the drug «Akvadetrim», drops for oral administration, 15000 IU / ml, РУ П N014088/01.]
26. Инструкция по медицинскому применению лекарственного препарата «Аквадетрим», таблетки растворимые, 1000 и 2000 МЕ РУ ЛП-006732 и «Аквадетрим», таблетки растворимые, 500 МЕ РУ ЛП-N (000047) – (РГ-RU). [Instructions for medical use of the drug «Aquadetrim«, soluble tablets, 1000 and 2000 IU РУ ЛП-006732; «Aquadetrim«, soluble tablets, 500 IU RU LP-N (000047) – (RG-RU).
Review
For citations:
Dukhanin A.S. Vitamin D drug formulation: from active substance to therapeutic effects. Lechaschi Vrach. 2022;(9):66-71. (In Russ.) https://doi.org/10.51793/OS.2022.25.9.001
Views:
3003
JATS XML
Email this article 
